Analyst Davides holds a conference call with CEO Chowdhury to discuss the Company’s non-invasive glucose monitoring device, commercial strategy and regulatory progress with the FDA on March 29 at 10 am hosted by EF Hutton. Webcast Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NMRD:
- Nemaura Medical participates in a conference call with EF Hutton
- Nemaura includes insulin on list of drugs eligible for EU DuoPack license
- Nemaura Includes Insulin on List of Drugs Eligible for EU DuoPack License Agreement
- Nemaura Medical Announces Receipt of Notice from Nasdaq
- Nemaura Medical receives Nasdaq noncompliance notice
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue